Top

Published in:

01-12-2009 | Original Article

Reduction of chemotherapy-induced anorexia, nausea, and emesis through a structured nursing intervention: a cluster-randomized multicenter trial

Authors: Patrick Jahn, Petra Renz, Joerg Stukenkemper, Katrin Book, Oliver Kuss, Karin Jordan, Ingrid Horn, Anette Thoke-Colberg, Hans-Joachim Schmoll, Margarete Landenberger

Published in: Supportive Care in Cancer | Issue 12/2009

Abstract

Objectives

The purpose of this present study was to evaluate Self-care Improvement through Oncology Nursing (SCION) program to reduce distressing anorexia, nausea, and emesis (ANE) in cancer patients undergoing chemotherapy.

Methods

Two hundred eight patients receiving chemotherapy with moderate to high emetogenic potential participated in a cluster randomized trial on 14 wards in two German university hospitals. Additionally to standard antiemetic treatment, patients from the intervention wards received the SCION program consisting of four modules: advisory consultation, optimizing emesis prophylaxis, nutrition counseling, and relaxation. Patients from the control group received standard antiemetic treatment and standard care. Primary outcome was the group difference in ANE intensity assessed by Common Terminology Criteria for adverse events (CTCAE).

Main results

The SCION program did not result in a significant difference in the incidence of ANE symptoms as compared to standard care: mean difference on CTCAE scale was 0.24 pts (95%CI, −1.17 to 1.66 pts; P = 0.733). No difference could be found regarding patients’ knowledge of side effects, self-care interventions, and agency. Health-related quality of life was significantly better for patients in the control group (mean difference 10.2 pts; 95%CI, 1.9 to 18.5; P = 0.017).

Conclusions

Contrary to our expectations, the groups did not differ in ANE intensity caused by the overall low acute or delayed symptom intensity. Symptom hierarchy in cancer patients alters and challenges nursing interventions targeting the patients’ self-care strategies.

Aapro MS, Molassiotis A, Olver I (2005) Anticipatory nausea and vomiting. Support Care Cancer 13(2):117–121CrossRefPubMed

Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376CrossRefPubMed

Ashbury FD, Findlay H, Reynolds B, McKerracher K (1998) A Canadian survey of cancer patients’ experiences: are their needs being met? J Pain Symptom Manage 16(5):298–306CrossRefPubMed

Baldwin C, Parsons T, Logan S (2007) Dietary advice for illness-related malnutrition in adults. Cochrane Database Syst Rev 1:CD002008PubMed

Ballatori E, Roila F (2003) Impact of nausea and vomiting on quality of life in cancer patients during chemotherapy. Health Qual Life Outcomes 1:1–11CrossRef

Benor DE, Delbar V, Krulik T (1998) Measuring impact of nursing intervention on cancer patients’ ability to control symptoms. Cancer Nurs 21(5):320–334CrossRefPubMed

Borjeson S, Hursti TJ, Tishelman C, Peterson C, Steineck G (2002) Treatment of nausea and emesis during cancer chemotherapy. Discrepancies between antiemetic effect and well-being. J Pain Symptom Manage 24(3):345–358CrossRefPubMed

Devine EC, Westlake SK (1995) The effects of psychoeducational care provided to adults with cancer: meta-analysis of 116 studies. Oncol Nurs Forum 22(9):1369–1381PubMed

Evers G, De Maesschalck L, Brouns G, Isenberg M, Philipsen H (2002) Die ASA-A-Skala für die Selbstbeurteilung. In: Evers G (ed) Professionelle Selbstpflege: Einschätzen-Messen-Anwenden. Huber, Bern, pp 59–89

10.

Feyer P, Kleeberg UR, Steingraber M, Gunther W, Behrens M (2008) Frequency of side effects in outpatient cancer care and their influence on patient satisfaction—a prospective survey using the PASQOC questionnaire. Support Care Cancer 16(6):567–575CrossRefPubMed

11.

Figueroa-Moseley C, Jean-Pierre P, Roscoe JA et al (2007) Behavioral interventions in treating anticipatory nausea and vomiting. J Natl Compr Canc Netw 5(1):44–50PubMed

12.

Foubert J, Vaessen G (2005) Nausea the neglected symptom? Eur J Oncol Nurs 9(1):21–32CrossRefPubMed

13.

Griffin AM, Butow PN, Coates AS et al (1996) On the receiving end. V: patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 7(2):189–195PubMed

14.

Grunberg SM, Deuson RR, Mavros P et al (2004) Incidence of chemotherapy-induced nausea and emesis after modern antiemetics. Cancer 100(10):2261–2268CrossRefPubMed

15.

Hesketh PJ (2008) Chemotherapy-induced nausea and vomiting. N Engl J Med 358(23):2482–2494CrossRefPubMed

16.

Hesketh PJ (1999) Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice. Oncologist 4(3):191–196PubMed

17.

Hofman M, Morrow G, Roscoe J et al (2004) Cancer patients’ expectations of experiencing treatment-related side effects. Cancer 101:851–857CrossRefPubMed

18.

Ihbe-Heffinger A, Ehlken B, Bernard R et al (2004) The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers. Ann Oncol 15(3):526–536CrossRefPubMed

19.

Knobf MT (2007) Psychosocial responses in breast cancer survivors. Sem Oncol Nurs 23(1):71–83CrossRef

20.

Kris MG, Hesketh PJ, Somerfield MR et al (2006) American Society of Clinical Oncology Guideline for Antiemetics in Oncology: update 2006. J Clin Oncol 24(18):2932–2947CrossRefPubMed

21.

Lakusta CM, Atkinson MJ, Robinson JW, Nation J, Taenzer PA, Campo MG (2001) Quality of life in ovarian cancer patients receiving chemotherapy. Gynecol Oncol 81(3):490–495CrossRefPubMed

22.

McQuellon RP, Wells M, Hoffman S et al (1998) Reducing distress in cancer patients with an orientation program. Psychooncology 7(3):207–217CrossRefPubMed

23.

Milne AC, Potter J, Avenell A (2005) Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database Syst Rev 2:CD003288PubMed

24.

Murray D (1998) Design and analysis of group-randomized trials. Oxford University Press, New York

25.

Osoba D, Zee B, Warr D, Latreille J, Kaizer L, Pater J (1997) Effect of postchemotherapy nausea and vomiting on health-related quality of life. The quality of life and symptom control committees of the National Cancer Institute of Canada clinical trials group. Support Care Cancer 5(4):307–313CrossRefPubMed

26.

Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME (2005) Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol 23(7):1431–1438CrossRefPubMed

27.

RCN (2002) Principles for best practice in clinical audit. National Institute for Clinical Excellence, London

28.

Roila F, Hesketh PJ, Herrstedt J (2006) Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference. Ann Oncol 17(1):20–28CrossRefPubMed

29.

Roscoe JA, Bushunow P, Morrow GR et al (2004) Patient expectation is a strong predictor of severe nausea after chemotherapy: a University of Rochester Community Clinical Oncology Program study of patients with breast carcinoma. Cancer 101(11):2701–2708CrossRefPubMed

30.

Rothwell PM (2005) Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet 365(9454):176–86CrossRefPubMed

31.

Tanghe A, Vandekerckhove L, Bras L et al (2002) Der Selbstpflege-Fragebogen für Beschwerden durch Chemotherapie. In: Evers G (ed) Professionelle Selbstpflege: Einschätzen-Messen-Anwenden. Hans Huber, Bern, pp 263–287

32.

Tipton JM, McDaniel RW, Barbour L et al (2007) Putting evidence into practice: evidence-based interventions to prevent, manage, and treat chemotherapy-induced nausea and vomiting. Clin J Oncol Nurs; 11(1):69–78CrossRefPubMed

33.

Williams SA, Schreier AM (2004) The effect of education in managing side effects in women receiving chemotherapy for treatment of breast cancer. Oncol Nurs Forum 31(1):E16–E23CrossRefPubMed

Title: Reduction of chemotherapy-induced anorexia, nausea, and emesis through a structured nursing intervention: a cluster-randomized multicenter trial
Authors: Patrick Jahn
Petra Renz
Joerg Stukenkemper
Katrin Book
Oliver Kuss
Karin Jordan
Ingrid Horn
Anette Thoke-Colberg
Hans-Joachim Schmoll
Margarete Landenberger
Publication date: 01-12-2009
Publisher: Springer-Verlag
Published in: Supportive Care in Cancer / Issue 12/2009
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-009-0698-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Methods

Main results

Conclusions

Please log in to get access to this content

Other articles of this Issue 12/2009

Is my patient suffering clinically significant emotional distress? Demonstration of a probabilities approach to evaluating algorithms for screening for distress

Reducing gastric secretions—a role for histamine 2 antagonists or proton pump inhibitors in malignant bowel obstruction?

Prevalence of emotional distress in newly diagnosed lung cancer patients

An exploratory study on the Italian patients’ preferences regarding how they would like to be told about their cancer

Parental stress before, during, and after pediatric stem cell transplantation: a review article

Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02

Keynote webinar | Spotlight on antibody–drug conjugates in cancer